It leaves Ireland particularly exposed to Trump’s trade tariffs.  “We have lots of global supply chains that are operating ...
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...
After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...
Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...
Eli Lilly and Company’s LLY shares dipped almost 5% on Monday after rival Novo Nordisk NVO announced disappointing data from ...
If you have questions about the possible FDA approval of Mounjaro for weight loss, talk with your doctor or pharmacist. Note: A drug called Zepbound is FDA approved to help with weight loss and ...
Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...
The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.